Mark McKenna, MD, MBA is a doctor that founded and owns OVME, a company in the elective healthcare industry. Dr. Mark McKenna was born in New Orleans and now has been licensed in by two State Board of Medical Examiners, Florida and Georgia. He earned his medical degree at Tulane University Medical School and started his first practice in New Orleans. In the aftermath of Hurricane Katrina he helped with rebuilding efforts before eventually moving to Atlanta, Georgia.

In November 2017 Dr. McKenna launched a company called ShapeMed. This company was involved in wellness as well as aesthetic based medicine. His success building this company led to it being bought by a larger company in the industry, Life Time Fitness, Inc. After the sale Dr. McKenna joined Life Time Fitness as their National Medical Director. He stayed with this company for three years before deciding to exit the company and take a year off to rejuvenate. It was in July 2017 that he established OVME and he leads the company as its chief executive officer.

Dr. McKenna has been very successful as an entrepreneur in the healthcare industry. It was while leading Shape Medical Wellness Center (more commonly known as ShapeMed), that he earned the “Black Diamond” certification that Allergan Inc. gives to its leading laser and aesthetic medicine doctors. Winning this award acknowledged the Dr. McKenna is one of the industry leaders in innovation and excellence while providing his patients the highest level of care. It’s not even 1% of MD’s across the United States that earn this designation who are affiliated with the Allergen physician network.

Dr. Mark McKenna has been a featured guest on a number of national shows due to his expertise in aesthetic medicine. Among these was the CBS television show Doctorpreneur which highlighted doctors who are also entrepreneurs. He was invited onto the very first show as one of their featured guests. This show aired on October 27th, 2013 and he was interviewed by Dr. Jeff Gallups, who leads the ENT Institute as its Medical Director and CEO as well as others such as Dr. Stanford Plavin who is the President of Mobile Anesthesiologist.

https://www.facebook.com/smarkmckenna

Oncotarget is an open-access medical journal which is peer-reviewed and covers all fields of oncology as well as issues related to microbiology, immunology, aging, and chromosomes. The Journal has over hundreds of board members and editors who are the specialist in the fields that the journal covers. It was founded in 2010, and it has published six volumes and over 300 issues since then. It is now on the 8th volume and issues 47 to 50 were processed by National Library of medicine. The journal is among the first to submit an entire issue of publication to PubMed. It is published in Impact Journals with weekly publications. Its editors-in-chief are Mikhail Blagosklonny and Andrei Gudkov who work at Rosewell park cancer institute. The journal works with high profile scientific directories in order to make scientific results and research available to all researchers working in the medical field, medical students and the general public. The journal has been publishing two issues weekly; on Tuesdays and Fridays in order to provide information and news immediately it comes out as well as cover all aspects of the medical field widely. In 2013, four of the board members were awarded the Breakthrough Prize in appreciation of the excellent work the journal is doing worldwide.

The Journal nurtures the application of basic and clinical science to fight diseases. It has largely contributed to the removal of borders between researchers and specialists, therefore, giving them a chance to learn from each other and improve the medical research field. This has greatly contributed to the progress of research institutes as well as individuals. The organization’s main objective is to create a world without diseases especially cancer. Therefore, it accepts research papers from all over the world.

According to MEDLINE, the journal plays a critical role in the medical field by publishing basic medical research papers while following ethics as well as good editorial practices. This is because it publishes each paper under the recommendations of the Committee on Publication Ethics and gives each paper a Direct Object Identifier (DOI). The journal accepts papers from researchers, edits them then publishes the papers and releases them under PubMed in their permanent form.

Facebook: https://www.facebook.com/Oncotarget/